Literature DB >> 16500023

Role of bone morphogenetic proteins in transitional cell carcinoma cells.

Isaac Yi Kim1, Seong Jin Kim.   

Abstract

Bone morphogenetic proteins (BMPs) are pleiotropic growth factors that signal through an interaction with the membrane receptors-type--IA, -IB, and -II (BMP-RIA, -RIB, and -RII, respectively). Although the prototypical members of this group of growth factors were isolated as osteoinductive factors, recently accumulated data have suggested that these factors regulate malignant cells. Herein, we review the data concerning BMPs in transitional cell carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500023     DOI: 10.1016/j.canlet.2005.10.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  Bone morphogenetic protein-2 levels are elevated in the patients with gastric cancer and correlate with disease progression.

Authors:  Yong Park; Myoung Hee Kang; Hee Yeon Seo; Joong Min Park; Chul Won Choi; Yeul Hong Kim; In Sun Kim; Jun Suk Kim; Sang Cheul Oh
Journal:  Med Oncol       Date:  2009-11-19       Impact factor: 3.064

2.  The Bone Morphogenesis Protein-2 (BMP-2) is associated with progression to metastatic disease in gastric cancer.

Authors:  Yong Park; Jee Won Kim; Dae Sik Kim; Eui Bae Kim; Se Jong Park; Jin Yong Park; Woo Suk Choi; Jong Gyu Song; Hee Yun Seo; Sang Cheul Oh; Byung Soo Kim; Jong Jae Park; Yeul Hong Kim; Jun Suk Kim
Journal:  Cancer Res Treat       Date:  2008-09-30       Impact factor: 4.679

3.  Effect of bone morphogenetic protein-2 on proliferation and apoptosis of gastric cancer cells.

Authors:  Junjie Zhang; Yanli Ge; Longe Sun; Jianchun Cao; Qiong Wu; Likun Guo; Zhirong Wang
Journal:  Int J Med Sci       Date:  2012-02-15       Impact factor: 3.738

4.  Expression of bone morphogenetic protein-2 and -7 in urinary bladder cancer predicts time to tumor recurrence.

Authors:  Bolesław Kuzaka; Marek Janiak; Krzysztof H Włodarski; Piotr Radziszewski; Paweł K Włodarski
Journal:  Arch Med Sci       Date:  2015-03-18       Impact factor: 3.318

5.  Role of Smad proteins in resistance to BMP-induced growth inhibition in B-cell lymphoma.

Authors:  Kanutte Huse; Maren Bakkebø; Sébastien Wälchli; Morten P Oksvold; Vera I Hilden; Lise Forfang; May L Bredahl; Knut Liestøl; Ash A Alizadeh; Erlend B Smeland; June H Myklebust
Journal:  PLoS One       Date:  2012-10-01       Impact factor: 3.240

6.  Bone morphogenic proteins-2, -4, -6 and 7 in non-muscle invasive bladder cancer.

Authors:  Tvrtko Hudolin; Zeljko Kastelan; Ahmad El-Saleh; Mirko Bakula; Marijana Coric; Petar Kes; Davor Tomas; Nikolina Basic-Jukic
Journal:  Oncol Lett       Date:  2019-12-13       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.